世界のサイクリン依存性キナーゼ7市場インサイト及び予測(~2026年)

【英語タイトル】Global Cyclin Dependent Kinase 7 Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV00822)・商品コード:QYR20NV00822
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはサイクリン依存性キナーゼ7の世界市場について調査・分析した資料です。種類別(TG-02、SY-1365、セリシクリブ、ICEC-0942、その他)の市場規模、用途別(結腸直腸癌、嚢胞性線維症、炎症、膵臓癌、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別サイクリン依存性キナーゼ7の競争状況、市場シェア
・世界のサイクリン依存性キナーゼ7市場:種類別市場規模 2015年-2020年(TG-02、SY-1365、セリシクリブ、ICEC-0942、その他)
・世界のサイクリン依存性キナーゼ7市場:種類別市場規模予測 2021年-2026年(TG-02、SY-1365、セリシクリブ、ICEC-0942、その他)
・世界のサイクリン依存性キナーゼ7市場:用途別市場規模 2015年-2020年(結腸直腸癌、嚢胞性線維症、炎症、膵臓癌、その他)
・世界のサイクリン依存性キナーゼ7市場:用途別市場規模予測 2021年-2026年(結腸直腸癌、嚢胞性線維症、炎症、膵臓癌、その他)
・北米のサイクリン依存性キナーゼ7市場分析:米国、カナダ
・ヨーロッパのサイクリン依存性キナーゼ7市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのサイクリン依存性キナーゼ7市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のサイクリン依存性キナーゼ7市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのサイクリン依存性キナーゼ7市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Aurigene Discovery Technologies Ltd、Beta Pharma Inc、Cyclacel Pharmaceuticals Inc、Qurient Co Ltd、Syros Pharmaceuticals Inc
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Cyclin Dependent Kinase 7 Market
The global Cyclin Dependent Kinase 7 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Cyclin Dependent Kinase 7 Scope and Market Size
Cyclin Dependent Kinase 7 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cyclin Dependent Kinase 7 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Cyclin Dependent Kinase 7 market is segmented into
TG-02
SY-1365
Seliciclib
ICEC-0942
Others

Segment by Application, the Cyclin Dependent Kinase 7 market is segmented into
Colorectal Cancer
Cystic Fibrosis
Inflammation
Pancreatic Cancer
Others

Regional and Country-level Analysis
The Cyclin Dependent Kinase 7 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cyclin Dependent Kinase 7 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cyclin Dependent Kinase 7 Market Share Analysis
Cyclin Dependent Kinase 7 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cyclin Dependent Kinase 7 business, the date to enter into the Cyclin Dependent Kinase 7 market, Cyclin Dependent Kinase 7 product introduction, recent developments, etc.

The major vendors covered:
Aurigene Discovery Technologies Ltd
Beta Pharma Inc
Cyclacel Pharmaceuticals Inc
Qurient Co Ltd
Syros Pharmaceuticals Inc

【レポートの目次】

1 Study Coverage
1.1 Cyclin Dependent Kinase 7 Product Introduction
1.2 Market Segments
1.3 Key Cyclin Dependent Kinase 7 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cyclin Dependent Kinase 7 Market Size Growth Rate by Type
1.4.2 TG-02
1.4.3 SY-1365
1.4.4 Seliciclib
1.4.5 ICEC-0942
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cyclin Dependent Kinase 7 Market Size Growth Rate by Application
1.5.2 Colorectal Cancer
1.5.3 Cystic Fibrosis
1.5.4 Inflammation
1.5.5 Pancreatic Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Cyclin Dependent Kinase 7 Market Size, Estimates and Forecasts
2.1.1 Global Cyclin Dependent Kinase 7 Revenue 2015-2026
2.1.2 Global Cyclin Dependent Kinase 7 Sales 2015-2026
2.2 Global Cyclin Dependent Kinase 7, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cyclin Dependent Kinase 7 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cyclin Dependent Kinase 7 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Cyclin Dependent Kinase 7 Competitor Landscape by Players
3.1 Cyclin Dependent Kinase 7 Sales by Manufacturers
3.1.1 Cyclin Dependent Kinase 7 Sales by Manufacturers (2015-2020)
3.1.2 Cyclin Dependent Kinase 7 Sales Market Share by Manufacturers (2015-2020)
3.2 Cyclin Dependent Kinase 7 Revenue by Manufacturers
3.2.1 Cyclin Dependent Kinase 7 Revenue by Manufacturers (2015-2020)
3.2.2 Cyclin Dependent Kinase 7 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cyclin Dependent Kinase 7 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cyclin Dependent Kinase 7 Revenue in 2019
3.2.5 Global Cyclin Dependent Kinase 7 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cyclin Dependent Kinase 7 Price by Manufacturers
3.4 Cyclin Dependent Kinase 7 Manufacturing Base Distribution, Product Types
3.4.1 Cyclin Dependent Kinase 7 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cyclin Dependent Kinase 7 Product Type
3.4.3 Date of International Manufacturers Enter into Cyclin Dependent Kinase 7 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cyclin Dependent Kinase 7 Market Size by Type (2015-2020)
4.1.1 Global Cyclin Dependent Kinase 7 Sales by Type (2015-2020)
4.1.2 Global Cyclin Dependent Kinase 7 Revenue by Type (2015-2020)
4.1.3 Cyclin Dependent Kinase 7 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cyclin Dependent Kinase 7 Market Size Forecast by Type (2021-2026)
4.2.1 Global Cyclin Dependent Kinase 7 Sales Forecast by Type (2021-2026)
4.2.2 Global Cyclin Dependent Kinase 7 Revenue Forecast by Type (2021-2026)
4.2.3 Cyclin Dependent Kinase 7 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cyclin Dependent Kinase 7 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Cyclin Dependent Kinase 7 Market Size by Application (2015-2020)
5.1.1 Global Cyclin Dependent Kinase 7 Sales by Application (2015-2020)
5.1.2 Global Cyclin Dependent Kinase 7 Revenue by Application (2015-2020)
5.1.3 Cyclin Dependent Kinase 7 Price by Application (2015-2020)
5.2 Cyclin Dependent Kinase 7 Market Size Forecast by Application (2021-2026)
5.2.1 Global Cyclin Dependent Kinase 7 Sales Forecast by Application (2021-2026)
5.2.2 Global Cyclin Dependent Kinase 7 Revenue Forecast by Application (2021-2026)
5.2.3 Global Cyclin Dependent Kinase 7 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Cyclin Dependent Kinase 7 by Country
6.1.1 North America Cyclin Dependent Kinase 7 Sales by Country
6.1.2 North America Cyclin Dependent Kinase 7 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cyclin Dependent Kinase 7 Market Facts & Figures by Type
6.3 North America Cyclin Dependent Kinase 7 Market Facts & Figures by Application

7 Europe
7.1 Europe Cyclin Dependent Kinase 7 by Country
7.1.1 Europe Cyclin Dependent Kinase 7 Sales by Country
7.1.2 Europe Cyclin Dependent Kinase 7 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cyclin Dependent Kinase 7 Market Facts & Figures by Type
7.3 Europe Cyclin Dependent Kinase 7 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Cyclin Dependent Kinase 7 by Region
8.1.1 Asia Pacific Cyclin Dependent Kinase 7 Sales by Region
8.1.2 Asia Pacific Cyclin Dependent Kinase 7 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cyclin Dependent Kinase 7 Market Facts & Figures by Type
8.3 Asia Pacific Cyclin Dependent Kinase 7 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Cyclin Dependent Kinase 7 by Country
9.1.1 Latin America Cyclin Dependent Kinase 7 Sales by Country
9.1.2 Latin America Cyclin Dependent Kinase 7 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cyclin Dependent Kinase 7 Market Facts & Figures by Type
9.3 Central & South America Cyclin Dependent Kinase 7 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Cyclin Dependent Kinase 7 by Country
10.1.1 Middle East and Africa Cyclin Dependent Kinase 7 Sales by Country
10.1.2 Middle East and Africa Cyclin Dependent Kinase 7 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cyclin Dependent Kinase 7 Market Facts & Figures by Type
10.3 Middle East and Africa Cyclin Dependent Kinase 7 Market Facts & Figures by Application

11 Company Profiles
11.1 Aurigene Discovery Technologies Ltd
11.1.1 Aurigene Discovery Technologies Ltd Corporation Information
11.1.2 Aurigene Discovery Technologies Ltd Description and Business Overview
11.1.3 Aurigene Discovery Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurigene Discovery Technologies Ltd Cyclin Dependent Kinase 7 Products Offered
11.1.5 Aurigene Discovery Technologies Ltd Related Developments
11.2 Beta Pharma Inc
11.2.1 Beta Pharma Inc Corporation Information
11.2.2 Beta Pharma Inc Description and Business Overview
11.2.3 Beta Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Beta Pharma Inc Cyclin Dependent Kinase 7 Products Offered
11.2.5 Beta Pharma Inc Related Developments
11.3 Cyclacel Pharmaceuticals Inc
11.3.1 Cyclacel Pharmaceuticals Inc Corporation Information
11.3.2 Cyclacel Pharmaceuticals Inc Description and Business Overview
11.3.3 Cyclacel Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cyclacel Pharmaceuticals Inc Cyclin Dependent Kinase 7 Products Offered
11.3.5 Cyclacel Pharmaceuticals Inc Related Developments
11.4 Qurient Co Ltd
11.4.1 Qurient Co Ltd Corporation Information
11.4.2 Qurient Co Ltd Description and Business Overview
11.4.3 Qurient Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Qurient Co Ltd Cyclin Dependent Kinase 7 Products Offered
11.4.5 Qurient Co Ltd Related Developments
11.5 Syros Pharmaceuticals Inc
11.5.1 Syros Pharmaceuticals Inc Corporation Information
11.5.2 Syros Pharmaceuticals Inc Description and Business Overview
11.5.3 Syros Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Syros Pharmaceuticals Inc Cyclin Dependent Kinase 7 Products Offered
11.5.5 Syros Pharmaceuticals Inc Related Developments
11.1 Aurigene Discovery Technologies Ltd
11.1.1 Aurigene Discovery Technologies Ltd Corporation Information
11.1.2 Aurigene Discovery Technologies Ltd Description and Business Overview
11.1.3 Aurigene Discovery Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurigene Discovery Technologies Ltd Cyclin Dependent Kinase 7 Products Offered
11.1.5 Aurigene Discovery Technologies Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cyclin Dependent Kinase 7 Market Estimates and Projections by Region
12.1.1 Global Cyclin Dependent Kinase 7 Sales Forecast by Regions 2021-2026
12.1.2 Global Cyclin Dependent Kinase 7 Revenue Forecast by Regions 2021-2026
12.2 North America Cyclin Dependent Kinase 7 Market Size Forecast (2021-2026)
12.2.1 North America: Cyclin Dependent Kinase 7 Sales Forecast (2021-2026)
12.2.2 North America: Cyclin Dependent Kinase 7 Revenue Forecast (2021-2026)
12.2.3 North America: Cyclin Dependent Kinase 7 Market Size Forecast by Country (2021-2026)
12.3 Europe Cyclin Dependent Kinase 7 Market Size Forecast (2021-2026)
12.3.1 Europe: Cyclin Dependent Kinase 7 Sales Forecast (2021-2026)
12.3.2 Europe: Cyclin Dependent Kinase 7 Revenue Forecast (2021-2026)
12.3.3 Europe: Cyclin Dependent Kinase 7 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cyclin Dependent Kinase 7 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cyclin Dependent Kinase 7 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cyclin Dependent Kinase 7 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cyclin Dependent Kinase 7 Market Size Forecast by Region (2021-2026)
12.5 Latin America Cyclin Dependent Kinase 7 Market Size Forecast (2021-2026)
12.5.1 Latin America: Cyclin Dependent Kinase 7 Sales Forecast (2021-2026)
12.5.2 Latin America: Cyclin Dependent Kinase 7 Revenue Forecast (2021-2026)
12.5.3 Latin America: Cyclin Dependent Kinase 7 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cyclin Dependent Kinase 7 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cyclin Dependent Kinase 7 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cyclin Dependent Kinase 7 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cyclin Dependent Kinase 7 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cyclin Dependent Kinase 7 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cyclin Dependent Kinase 7 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Cyclin Dependent Kinase 7 Market Segments
Table 2. Ranking of Global Top Cyclin Dependent Kinase 7 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cyclin Dependent Kinase 7 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of TG-02
Table 5. Major Manufacturers of SY-1365
Table 6. Major Manufacturers of Seliciclib
Table 7. Major Manufacturers of ICEC-0942
Table 8. Major Manufacturers of Others
Table 9. Global Cyclin Dependent Kinase 7 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Cyclin Dependent Kinase 7 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Cyclin Dependent Kinase 7 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Cyclin Dependent Kinase 7 Sales Market Share by Regions (2015-2020)
Table 13. Global Cyclin Dependent Kinase 7 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Cyclin Dependent Kinase 7 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Cyclin Dependent Kinase 7 Sales Share by Manufacturers (2015-2020)
Table 16. Global Cyclin Dependent Kinase 7 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Cyclin Dependent Kinase 7 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclin Dependent Kinase 7 as of 2019)
Table 18. Cyclin Dependent Kinase 7 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Cyclin Dependent Kinase 7 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Cyclin Dependent Kinase 7 Price (2015-2020) (USD/Pcs)
Table 21. Cyclin Dependent Kinase 7 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Cyclin Dependent Kinase 7 Product Type
Table 23. Date of International Manufacturers Enter into Cyclin Dependent Kinase 7 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Cyclin Dependent Kinase 7 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Cyclin Dependent Kinase 7 Sales Share by Type (2015-2020)
Table 27. Global Cyclin Dependent Kinase 7 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Cyclin Dependent Kinase 7 Revenue Share by Type (2015-2020)
Table 29. Cyclin Dependent Kinase 7 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Cyclin Dependent Kinase 7 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Cyclin Dependent Kinase 7 Sales Share by Application (2015-2020)
Table 32. North America Cyclin Dependent Kinase 7 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Cyclin Dependent Kinase 7 Sales Market Share by Country (2015-2020)
Table 34. North America Cyclin Dependent Kinase 7 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Cyclin Dependent Kinase 7 Revenue Market Share by Country (2015-2020)
Table 36. North America Cyclin Dependent Kinase 7 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Cyclin Dependent Kinase 7 Sales Market Share by Type (2015-2020)
Table 38. North America Cyclin Dependent Kinase 7 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Cyclin Dependent Kinase 7 Sales Market Share by Application (2015-2020)
Table 40. Europe Cyclin Dependent Kinase 7 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Cyclin Dependent Kinase 7 Sales Market Share by Country (2015-2020)
Table 42. Europe Cyclin Dependent Kinase 7 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Cyclin Dependent Kinase 7 Revenue Market Share by Country (2015-2020)
Table 44. Europe Cyclin Dependent Kinase 7 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Cyclin Dependent Kinase 7 Sales Market Share by Type (2015-2020)
Table 46. Europe Cyclin Dependent Kinase 7 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Cyclin Dependent Kinase 7 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Cyclin Dependent Kinase 7 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Cyclin Dependent Kinase 7 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Cyclin Dependent Kinase 7 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Cyclin Dependent Kinase 7 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Cyclin Dependent Kinase 7 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Cyclin Dependent Kinase 7 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Cyclin Dependent Kinase 7 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Cyclin Dependent Kinase 7 Sales Market Share by Application (2015-2020)
Table 56. Latin America Cyclin Dependent Kinase 7 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Cyclin Dependent Kinase 7 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Cyclin Dependent Kinase 7 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Cyclin Dependent Kinase 7 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Cyclin Dependent Kinase 7 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Cyclin Dependent Kinase 7 Sales Market Share by Type (2015-2020)
Table 62. Latin America Cyclin Dependent Kinase 7 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Cyclin Dependent Kinase 7 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Cyclin Dependent Kinase 7 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Cyclin Dependent Kinase 7 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Cyclin Dependent Kinase 7 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Cyclin Dependent Kinase 7 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Cyclin Dependent Kinase 7 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Cyclin Dependent Kinase 7 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Cyclin Dependent Kinase 7 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Cyclin Dependent Kinase 7 Sales Market Share by Application (2015-2020)
Table 72. Aurigene Discovery Technologies Ltd Corporation Information
Table 73. Aurigene Discovery Technologies Ltd Description and Major Businesses
Table 74. Aurigene Discovery Technologies Ltd Cyclin Dependent Kinase 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Aurigene Discovery Technologies Ltd Product
Table 76. Aurigene Discovery Technologies Ltd Recent Development
Table 77. Beta Pharma Inc Corporation Information
Table 78. Beta Pharma Inc Description and Major Businesses
Table 79. Beta Pharma Inc Cyclin Dependent Kinase 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Beta Pharma Inc Product
Table 81. Beta Pharma Inc Recent Development
Table 82. Cyclacel Pharmaceuticals Inc Corporation Information
Table 83. Cyclacel Pharmaceuticals Inc Description and Major Businesses
Table 84. Cyclacel Pharmaceuticals Inc Cyclin Dependent Kinase 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Cyclacel Pharmaceuticals Inc Product
Table 86. Cyclacel Pharmaceuticals Inc Recent Development
Table 87. Qurient Co Ltd Corporation Information
Table 88. Qurient Co Ltd Description and Major Businesses
Table 89. Qurient Co Ltd Cyclin Dependent Kinase 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Qurient Co Ltd Product
Table 91. Qurient Co Ltd Recent Development
Table 92. Syros Pharmaceuticals Inc Corporation Information
Table 93. Syros Pharmaceuticals Inc Description and Major Businesses
Table 94. Syros Pharmaceuticals Inc Cyclin Dependent Kinase 7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Syros Pharmaceuticals Inc Product
Table 96. Syros Pharmaceuticals Inc Recent Development
Table 97. Global Cyclin Dependent Kinase 7 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Cyclin Dependent Kinase 7 Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Cyclin Dependent Kinase 7 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Cyclin Dependent Kinase 7 Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Cyclin Dependent Kinase 7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Cyclin Dependent Kinase 7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Cyclin Dependent Kinase 7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Cyclin Dependent Kinase 7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Cyclin Dependent Kinase 7 Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Cyclin Dependent Kinase 7 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Cyclin Dependent Kinase 7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Cyclin Dependent Kinase 7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Cyclin Dependent Kinase 7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Cyclin Dependent Kinase 7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Cyclin Dependent Kinase 7 Players
Table 115. Cyclin Dependent Kinase 7 Customers List
Table 116. Cyclin Dependent Kinase 7 Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyclin Dependent Kinase 7 Product Picture
Figure 2. Global Cyclin Dependent Kinase 7 Sales Market Share by Type in 2020 & 2026
Figure 3. TG-02 Product Picture
Figure 4. SY-1365 Product Picture
Figure 5. Seliciclib Product Picture
Figure 6. ICEC-0942 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cyclin Dependent Kinase 7 Sales Market Share by Application in 2020 & 2026
Figure 9. Colorectal Cancer
Figure 10. Cystic Fibrosis
Figure 11. Inflammation
Figure 12. Pancreatic Cancer
Figure 13. Others
Figure 14. Cyclin Dependent Kinase 7 Report Years Considered
Figure 15. Global Cyclin Dependent Kinase 7 Market Size 2015-2026 (US$ Million)
Figure 16. Global Cyclin Dependent Kinase 7 Sales 2015-2026 (K Pcs)
Figure 17. Global Cyclin Dependent Kinase 7 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Cyclin Dependent Kinase 7 Sales Market Share by Region (2015-2020)
Figure 19. Global Cyclin Dependent Kinase 7 Sales Market Share by Region in 2019
Figure 20. Global Cyclin Dependent Kinase 7 Revenue Market Share by Region (2015-2020)
Figure 21. Global Cyclin Dependent Kinase 7 Revenue Market Share by Region in 2019
Figure 22. Global Cyclin Dependent Kinase 7 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Cyclin Dependent Kinase 7 Revenue in 2019
Figure 24. Cyclin Dependent Kinase 7 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Cyclin Dependent Kinase 7 Sales Market Share by Type (2015-2020)
Figure 26. Global Cyclin Dependent Kinase 7 Sales Market Share by Type in 2019
Figure 27. Global Cyclin Dependent Kinase 7 Revenue Market Share by Type (2015-2020)
Figure 28. Global Cyclin Dependent Kinase 7 Revenue Market Share by Type in 2019
Figure 29. Global Cyclin Dependent Kinase 7 Market Share by Price Range (2015-2020)
Figure 30. Global Cyclin Dependent Kinase 7 Sales Market Share by Application (2015-2020)
Figure 31. Global Cyclin Dependent Kinase 7 Sales Market Share by Application in 2019
Figure 32. Global Cyclin Dependent Kinase 7 Revenue Market Share by Application (2015-2020)
Figure 33. Global Cyclin Dependent Kinase 7 Revenue Market Share by Application in 2019
Figure 34. North America Cyclin Dependent Kinase 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Cyclin Dependent Kinase 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Cyclin Dependent Kinase 7 Sales Market Share by Country in 2019
Figure 37. North America Cyclin Dependent Kinase 7 Revenue Market Share by Country in 2019
Figure 38. U.S. Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Cyclin Dependent Kinase 7 Market Share by Type in 2019
Figure 43. North America Cyclin Dependent Kinase 7 Market Share by Application in 2019
Figure 44. Europe Cyclin Dependent Kinase 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Cyclin Dependent Kinase 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Cyclin Dependent Kinase 7 Sales Market Share by Country in 2019
Figure 47. Europe Cyclin Dependent Kinase 7 Revenue Market Share by Country in 2019
Figure 48. Germany Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Cyclin Dependent Kinase 7 Market Share by Type in 2019
Figure 59. Europe Cyclin Dependent Kinase 7 Market Share by Application in 2019
Figure 60. Asia Pacific Cyclin Dependent Kinase 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Cyclin Dependent Kinase 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Cyclin Dependent Kinase 7 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Cyclin Dependent Kinase 7 Revenue Market Share by Region in 2019
Figure 64. China Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Cyclin Dependent Kinase 7 Market Share by Type in 2019
Figure 87. Asia Pacific Cyclin Dependent Kinase 7 Market Share by Application in 2019
Figure 88. Latin America Cyclin Dependent Kinase 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Cyclin Dependent Kinase 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Cyclin Dependent Kinase 7 Sales Market Share by Country in 2019
Figure 91. Latin America Cyclin Dependent Kinase 7 Revenue Market Share by Country in 2019
Figure 92. Mexico Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Cyclin Dependent Kinase 7 Market Share by Type in 2019
Figure 99. Latin America Cyclin Dependent Kinase 7 Market Share by Application in 2019
Figure 100. Middle East and Africa Cyclin Dependent Kinase 7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Cyclin Dependent Kinase 7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Cyclin Dependent Kinase 7 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Cyclin Dependent Kinase 7 Revenue Market Share by Country in 2019
Figure 104. Turkey Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Cyclin Dependent Kinase 7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Cyclin Dependent Kinase 7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Cyclin Dependent Kinase 7 Market Share by Type in 2019
Figure 111. Middle East and Africa Cyclin Dependent Kinase 7 Market Share by Application in 2019
Figure 112. North America Cyclin Dependent Kinase 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Cyclin Dependent Kinase 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Cyclin Dependent Kinase 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Cyclin Dependent Kinase 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Cyclin Dependent Kinase 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Cyclin Dependent Kinase 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Cyclin Dependent Kinase 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Cyclin Dependent Kinase 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Cyclin Dependent Kinase 7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Cyclin Dependent Kinase 7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed


【掲載企業】

Aurigene Discovery Technologies Ltd、Beta Pharma Inc、Cyclacel Pharmaceuticals Inc、Qurient Co Ltd、Syros Pharmaceuticals Inc

★調査レポート[世界のサイクリン依存性キナーゼ7市場インサイト及び予測(~2026年)] (コード:QYR20NV00822)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のサイクリン依存性キナーゼ7市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆